Brain tumor treatment with MRI-guided stereotactic laser ablation

MRI-guided stereotactic laser ablation is a minimally invasive surgical method for treating brain tumors. The therapy is effective if the lesion is in hard-to-reach areas or near critical structures such as large vessels or brain centers. This 12-day inpatient treatment package involves examinations, laboratory tests, brain MRI and other diagnostic procedures, and consultation with specialists to ensure the patient's suitability for the surgery. The process starts with a stereotactic system placement. Next, the patient undergoes general anesthesia, and the neurosurgeon creates a tiny hole in the skull to access the brain. A flexible laser catheter is inserted and directed toward the tumor. Once the catheter reaches the location, laser energy emits to remove the neoplasm. The surrounding healthy tissue remains safe because of close real-time MRI monitoring, which provides exact data about the temperature of nearby tissues. After the procedure, the surgeon carefully removes the catheter and closes the incision. The patient's condition after the treatment is closely watched to reduce side effects. This operation significantly reduces the open surgery risks like bleeding and infection and shortens recovery time. Most patients can return home and resume normal activities in a few days. Doctors will provide all needed recommendations and discharge medical records.